News from AstraZeneca, Royal DSM and the FDA – People on the move
We begin our weekly pharma job round-up with news that one of the big boys, AstraZeneca, has appointed Marc Dunoyer to the role of Executive Vice President, Global Portfolio & Product Strategy.
Next up we have global science based company Royal DSM who will propose in May’s AGM the appointment of Dimitri de Vreeze to the Managing Board.
Regulatory news now as the US Food and Drug Administration (FDA) has announced Dr. Kathleen Uhl will serve as acting director of the Office of Generic Drugs (OGD).
Elan has, as of the beginning of this month, appointed John Given as General Counsel.
According to Genocea Biosciences’s CEO, the appointment of Katrine Bosley “brings a unique and important perspective” to the company’s Board of Directors.
Dr. Ed Mascioli, who has previously served as a senior executive at Pfizer, has been announced as the CEO of Affinium Pharmaceuticals.
And finally for this week we bring news regarding Avanir Pharmaceuticals. The biopharmaceutical company has announced it has appointed Corinne Nevinny to its Board of Directors.
